NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
NADPH oxidase isoform-2 (NOX2) generates reactive oxygen species (ROS) that contribute to neurodegenerative and cardiovascular pathologies. However, validation of NOX2 as a pharmacotherapeutic target has been hampered by a lack of mechanistically-defined inhibitors. Using cellular and biochemical assays, we explored previously reported inhibitors of ROS production (perhexiline, suramin, VAS2870 and two Shionogi patent compounds) as direct NOX2 inhibitors. All but suramin, which presumably lacks cell penetrance, inhibit cellular ROS production. However, only perhexiline and suramin inhibit biochemical NOX2 activity. Indeed, our data suggest that NOX2 inhibition by perhexiline may contribute significantly to its demonstrated cardioprotective effects. Inhibition of protein kinase CβII explains the cellular activity of the Shionogi compounds, whereas VAS2870 inhibits by an as-yet unidentified mechanism unrelated to direct NOX2 function or subunit assembly. These data delineate the mechanisms of action of these compounds and highlight their strengths and limitations for use in future target validation studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in atherosclerosis
Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., & Drexler, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03144-2 · Cited by 1,275
Pollock, J. D., Williams, D. A., Gifford, M. A. C., Li, L. L., Du, X., Fisherman, J., Orkin, S. H., Doerschuk, C. M., & Dinauer, M. C. (1995) · Nature Genetics · doi:10.1038/ng0295-202 · Cited by 921
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Babior, B. M. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.12.001 · Cited by 705
Tarpey, M. M., Wink, D. A., & Grisham, M. B. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00361.2003 · Cited by 673
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
The NADPH oxidase of professional phagocytes—prototype of the NOX electron transport chain systems
Cross, A. R., & Segal, A. W. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.03.008 · Cited by 489
TENFREYHAUS, H., HUNTGEBURTH, M., WINGLER, K., SCHNITKER, J., BAUMER, A., VANTLER, M., BEKHITE, M., WARTENBERG, M., SAUER, H., & ROSENKRANZ, S. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.022 · Cited by 259 · cited 1×
“Such a conclusion appears inconsistent with prior findings from ten Freyhaus, et al.(34), who reported inhibition of NOX2 by VAS2870 in whole cell lysates.”
ResultComparative pharmacology of chemically distinct nadph oxidase inhibitors
Wind, S., Beuerlein, K., Eucker, T., Müller, H., Scheurer, P., Armitage, M., Ho, H., Schmidt, H., & Wingler, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00920.x · Cited by 241 · cited 1×
“Journal of Enzyme Inhibition and Medicinal Chemistry a direct inhibitor of NOX2 contrasts with that given by Wind et al.(50), which probably reflects differences in our assay formats.”
Background
Research works printed but not linked: 42
- 10.1517/14728222.11.7.967 · DOI
- 10.1152/physrev.00044.2005 · DOI · Paper page
- Sirker A, 2007, Am J Nephrol, 27, 649, 10.1159/000109148 · DOI
- Paravicini TM, 2004, Drugs, 64, 2143, 10.2165/00003495-200464190-00001 · DOI
- 10.1016/j.freeradbiomed.2007.03.027 · DOI · Paper page
- 10.1161/hc0302.103712 · DOI · Paper page
- Landmesser U, 2002, Hypertension, 40, 511, 10.1161/01.HYP.0000032100.23772.98 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.105.607168 · DOI · Paper page
- Doerries C, 2007, Circ Res, 100, 894, 10.1161/01.RES.0000261657.76299.ff · DOI · Paper page
- 10.2337/dc08-s247 · DOI · Paper page
- 10.1089/ars.2009.2585 · DOI · Paper page
- O’Donnell BV, 1993, Biochem J, 290, 41, 10.1042/bj2900041 · DOI · Paper page
- 10.1165/ajrcmb.11.1.8018341 · DOI · Paper page
- DeLeo FR, 1995, J Biol Chem, 270, 26246, 10.1074/jbc.270.44.26246 · DOI · Paper page
- 10.1080/10623320213638 · DOI · Paper page
- 10.1016/j.abb.2006.11.010 · DOI
- 10.1016/j.pharmthera.2008.08.005 · DOI · Paper page
- 10.1161/hy1101.093423 · DOI · Paper page
- Rey FE, 2001, Circ Res, 89, 408, 10.1161/hh1701.096037 · DOI · Paper page
- Liu J, 2004, Circ Res, 95, 587, 10.1161/01.RES.0000142317.88591.e6 · DOI · Paper page
- 10.1016/j.bbrc.2003.11.173 · DOI
- 10.2174/138920008786049285 · DOI · Paper page
- 10.1016/j.ejphar.2005.11.058 · DOI
- 10.2165/00129784-200101030-00005 · doi:10.2165/00129784-200101030-00005
- Voogd TE, 1993, Pharmacol Rev, 45, 177, 10.1016/S0031-6997(25)00445-4 · DOI · Paper page
- Heyneman RA, 1987, Vet Res Commun, 11, 149, 10.1007/BF00344946 · doi:10.1007/bf00344946
- Sobey C, 2006, FASEB J, 20, A725, 10.1096/fasebj.20.4.A725-a · doi:10.1096/fasebj.20.4.a725-a
- Stielow C, 2006, Biochem Biophys Res Commun, 344, 200, 10.1016/j.bbrc.2006.03.114 · DOI
- Rotrosen D, 1993, J Biol Chem, 268, 14256, 10.1016/S0021-9258(19)85235-3 · DOI
- Fornwald JA, 2007, Methods Mol Biol, 388, 95, 10.1007/978-1-59745-457-5_5 · DOI
- Abo A, 1995, Meth Enzymol, 256, 268, 10.1016/0076-6879(95)56031-9 · DOI
- 10.1016/S0378-1119(01)00449-8 · DOI · Paper page
- 10.1271/bbb.63.1787 · DOI · Paper page
- Dekker LV, 2000, Biochem J, 347, 285, 10.1042/bj3470285 · doi:10.1042/bj3470285 · Paper page
- Korchak HM, 2001, J Biol Chem, 276, 8910, 10.1074/jbc.M008326200 · DOI · Paper page
- Loomis CR, 1988, J Biol Chem, 263, 1682, 10.1016/S0021-9258(19)77930-7 · DOI
- Kim C, 2006, J Leukoc Biol, 79, 223, 10.1189/jlb.0705371 · DOI · Paper page
- 10.1016/j.str.2007.02.002 · DOI · Paper page
- Stein CA, 1993, Cancer Res, 53, 2239
- 10.1016/0006-2952(96)00204-3 · DOI · Paper page
- Lopaschuk GD, 1989, Circ Res, 65, 378, 10.1161/01.RES.65.2.378 · DOI · Paper page
- 10.1097/00005344-200008000-00020 · doi:10.1097/00005344-200008000-00020
Cited by
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
NADPH Oxidases in Vascular Pathology
Konior, A., Schramm, A., Czesnikiewicz-Guzik, M., & Guzik, T. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 452
NADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor
Hirano, K., Chen, W. S., Chueng, A. L. W., Dunne, A. A., Seredenina, T., Filippova, A., Ramachandran, S., Bridges, A., Chaudry, L., Pettman, G., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6202 · Cited by 205
“Among other NOX inhibitors tested in this study only DPI, celastrol and suramin showed inhibition across the cellfree assays independently of readout, in agreement with previous reports suggesting that DPI is a irreversible inhibitor of NOX2 (14), that celastrol inhibits NOX2 directly and via binding to the p47 phox s…”
InfluentialSelf-citation
Metadata
- Authors
- Gatto, G. J., Ao, Z., Kearse, M. G., Zhou, M., Morales, C. R., Daniels, E., Bradley, B. T., Goserud, M. T., Goodman, K. B., Douglas, S. A., Harpel, M. R., & Johns, D. G.
- Venue
- Journal of Enzyme Inhibition and Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2011-12-03
- Volume
- 28
- Issue
- 1
- Pages
- 95-104
- ISSN
- 1475-6366 (ISSN-L)
- 1475-6374
- OpenAlex
- W2057348287
- Cited by
- 73
- References
- 9
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation. https://app.cochat.ai/papers/10.3109/14756366.2011.636360
- The paper
- Gatto, G. J., Ao, Z., Kearse, M. G., Zhou, M., Morales, C. R., Daniels, E., Bradley, B. T., Goserud, M. T., Goodman, K. B., Douglas, S. A., Harpel, M. R., & Johns, D. G. (2013). NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.3109/14756366.2011.636360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.